UnitedHealth (UNH): healthcare and rate exposure
How global shocks reach UNH
None of the tracked sector channels map to UnitedHealth (Health Care), so only geography applies. Stories centered on the United States register as exposure, because the company is registered in the United States.
Direction is a tendency across cycles, not a forecast. Sector mapping uses the Finnhub industry classification; geography uses country of registration, not revenue by region.
What actually moves UnitedHealth
UnitedHealth is a policy and medical-cost company that happens to carry a large debt stack. Commercial paper and long-term debt principal totaled $79.4 billion, with $6.1 billion due in 2026 and interest expense of $4.0 billion. Rates also affect the portfolio that holds premiums before claims are paid. Neither path is why operating earnings fell to $19.0 billion from $32.3 billion. The filing points to utilization, billing intensity and costly drugs against premiums that had already been priced.
The payer that dominates is the federal government. CMS premiums were 44% of consolidated revenue, up from 40%. Medicare Advantage benchmark changes, risk-adjustment audits and star ratings move the book more than oil, conflict or chips. A recession reaches it through employers cutting coverage, which the filing names.
Tariffs belong only if they raise drug or device prices enough to lift medical cost trend. That is an indirect path. The less obvious operational scar is Change Healthcare. The filing cites the 2024 cyberattack and says recently acquired businesses can carry extra vulnerability. Optum Health swung to an operating loss in 2025. A macro badge will not explain that swing.
Drawn from the annual filing cited below. Not a forecast and not investment advice.
What UnitedHealth sells and where it earns
UnitedHealth Group has two businesses. UnitedHealthcare sells health coverage: employer and individual plans, Medicare Advantage and Part D through its Medicare & Retirement unit, and Medicaid plans through Community & State. Optum sells health services and is split three ways. Optum Health delivers care through employed and affiliated physicians and runs value-based arrangements in which it takes on the cost of a patient's care. Optum Insight sells software, data analytics and administrative services to hospitals, health plans, state governments and life sciences companies. Optum Rx is a pharmacy benefit manager and pharmacy business. Much of Optum's revenue comes from UnitedHealthcare itself: $168.0 billion of Optum's $270.6 billion of 2025 revenue was intercompany. Consolidated revenue was $447.6 billion, but earnings from operations fell to $19.0 billion from $32.3 billion, and Optum Health swung to a $278 million operating loss. Premiums from risk-based products make up nearly 80% of revenue, so small misses in forecasting medical costs move profits sharply. The company had more than 390,000 employees at year end.
Customer concentration
Premium revenues from CMS were 44% of consolidated revenue in 2025, up from 40% in 2024 and 2023, most of it from UnitedHealthcare Medicare & Retirement. The federal government is by far the largest payer, so Medicare Advantage and Part D funding decisions carry more weight than any commercial account.
Debt
Commercial paper and long-term debt principal totaled $79.4 billion at December 31, 2025, with $6.1 billion due in 2026 and between $3.5 billion and $3.9 billion due in each year from 2027 through 2030; $58.7 billion is due after 2030. Interest expense was $4.0 billion in 2025.
Risk factors that moved this year
- Medical cost trend. Risk-based premiums are nearly 80% of revenue, and the filing lists higher utilization, provider billing intensity and new or costly drugs among factors that have pushed costs above what was priced into premiums. Earnings from operations fell to $19.0 billion in 2025 from $32.3 billion.
- Medicare Advantage funding and audits. The filing says CMS has reduced or frozen benchmarks before and further cuts are possible, that changes to risk adjustment and RADV audits can claw back payments, and that plans below four stars lose quality bonuses. CMS premiums rose to 44% of revenue from 40%.
- Cybersecurity after Change Healthcare. The filing cites the 2024 cyberattack on Change Healthcare, which involved protected health information, and warns that recently acquired or non-integrated businesses carry heightened vulnerabilities. These are the risks the 2025 filing foregrounds; they were not compared line by line with the 2024 10-K, and the legal proceedings note covering government investigations was not reviewed for this profile.
How this changes the exposure read
UnitedHealth is a policy stock more than a macro one. CMS premiums were 44% of revenue, so Medicare Advantage rate notices, risk adjustment changes and audits move it more than any of the six tracked shocks. Rates and Fed policy matter through the investment portfolio that holds premiums before claims are paid and through $79.4 billion of debt. Credit stress and recession act through employers cutting coverage, which the filing names as a risk. Oil, conflict and chip shocks have little direct reach. Tariffs that raise drug or device prices would feed medical costs, which the filing lists as a cost driver. The defensive sector label hides how sharply cost trend can swing profits.
Source: UnitedHealth Group 10-K, FY2025. Checked 2026-10-05. Figures are from the filing and may differ from the live stats above.
What is moving it now
Key stats
Recent filings
Related tickers
- Your US portfolio might not be a US portfolio
- How world events actually reach your portfolio
- Methodology and editorial policy
Quotes may be delayed. Information only, not investment advice.